Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing pre-exposure prophylaxis to uninfected...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
In this podcast, Sonia Singh, PhD, talks about HIV testing before HIV diagnosis in the Black population in the United States from 2013 to 2018, including ways to help make routine HIV testing more...
In this podcast, Jonathan Colasanti, MD, talks about caring for patients with HIV in 2021, including why some current care models are succeeding, why some are failing, and how to improve health outcomes for...
In this podcast, Joseph "J" Logan, PhD, discusses 3 structural social determinants of health associated with HIV care outcomes for Black people with HIV.
In this podcast, Vinay Pathak, PhD, discusses the implications of his research presented in the session “Live-Cell Imaging of HIV-1 Nuclear Import, Uncoating, and Proviruses” at the Conference on...
A new economic modeling study published in The Lancet HIV has shed light on interventions needed to reach national targets for the Ending the HIV Epidemic initiative. Infectious Diseases Consultant...
Dr Kaushal talks about M tuberculosis and HIV coinfection, the role of CD4-positive T cells in chronic immune activation, and the macaque model his team has used to study tuberculosis infection in...
Infectious Diseases Consultant spoke with Tingting Zhang, PhD, whose new study indicated that failure to initiate antiretroviral therapy (ART) within 18 months of discontinuation is common among Medicaid...
